The mystery of Pauling, Cameron, and Hoffer’s low-dose Intravenous Vitamin C efficacy (wherein th... more The mystery of Pauling, Cameron, and Hoffer’s low-dose Intravenous Vitamin C efficacy (wherein they only used 10g/day) may finally be settled. New research demonstrates that a newly discovered cytotoxic mechanism for IVC (intravenous vitamin c) is ATP depletion, such that very low dose IVC can be very cytotoxic if ascorbate-persistence is continuous and long-lasting. Continuous IVC can be even much more tolerable than conventional IVC, possibly more effective, and even safe even for G6PD-deficient patients. Continuous IVC was tried in a 1998 pilot study, but was limited, and without integrations or conventional intermittent bolus injections. Ascorbate-Persistence, as a concept, is gaining popularity as an integrative cancer-treatment strategy. There are substantial additional advantages of using an Ascorbate-Persistence maximized protocol.
The mystery of Pauling, Cameron, and Hoffer’s low-dose Intravenous Vitamin C efficacy (wherein th... more The mystery of Pauling, Cameron, and Hoffer’s low-dose Intravenous Vitamin C efficacy (wherein they only used 10g/day) may finally be settled. New research demonstrates that a newly discovered cytotoxic mechanism for IVC (intravenous vitamin c) is ATP depletion, such that very low dose IVC can be very cytotoxic if ascorbate-persistence is continuous and long-lasting. Continuous IVC can be even much more tolerable than conventional IVC, possibly more effective, and even safe even for G6PD-deficient patients. Continuous IVC was tried in a 1998 pilot study, but was limited, and without integrations or conventional intermittent bolus injections. Ascorbate-Persistence, as a concept, is gaining popularity as an integrative cancer-treatment strategy. There are substantial additional advantages of using an Ascorbate-Persistence maximized protocol.
Uploads
Papers by David Austin